TY  - GEN
AU  - Jacobs,L D
AU  - Cookfair,D L
AU  - Rudick,R A
AU  - Herndon,R M
AU  - Richert,J R
AU  - Salazar,A M
AU  - Fischer,J S
AU  - Goodkin,D E
AU  - Granger,C V
AU  - Simon,J H
TI  - A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)
SN  - 1352-4585
PY  - 1997///1114
KW  - Adolescent
KW  - Adult
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Clinical Protocols
KW  - standards
KW  - Double-Blind Method
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Injections, Intramuscular
KW  - Interferon-beta
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Patient Selection
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Research Design
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1177/135245859500100210
ER  -